๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Thyroid Cancer
Clinical trial register · China

Thyroid Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 13 Beijing 5 Fuzhou 4 Chengdu 3 Hangzhou 2
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai13 Beijing5 Fuzhou4 Chengdu3 Hangzhou2
All 21 locations
Target enrolment
to

Thyroid Cancer trials in China

30 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Effectiveness of WeChat-Supported Neck Rehabilitation Exercises on Early Recovery After Thyroidectomy
NCT07707401Thyroid Diseases, Thyroid Cancer, Surgery, Postoperative Pain
Shanghai 6th People's Hospital
Not applicable
200
Shanghai
2026-09-09
Recruiting
Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid Cancer
NCT07777536Thyroid Cancer
Fudan University
Phase 2
72
Shanghai
2026-08-12
Recruiting
Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer
NCT07753499Tumor, Solid Tumor, Thyroid Cancer
The First Affiliated Hospital of Xiamen University
Not applicable
120
Xiamen
2026-08-01
Recruiting
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
NCT07459283Maligant Solid Tumor, Head & Neck Cancer, Thyroid Cancer, Lung Cancer - Non Small Cell Squamous
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1
10
Wuxi
2026-04-20
Recruiting
177Lu-CTR-FAPI for the Treatment of Thyroid Cancer
NCT07438847Thyroid Cancer
SHAOYAN LIU
Phase 1
12
Beijing
2026-01-01
Recruiting
Development and Application of an AI Chatbot for Perioperative Health Education in Thyroid Cancer Patients
NCT07634978Thyroid Cancer
Tianjin Medical University Cancer Institute and Hospital
Not applicable
150
Tianjin
2026-01-01
Recruiting
Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer
NCT07419932Thyroid Cancer, Thyroid Neoplasms
Fujian Medical University
Observational
120
Fuzhou
2025-12-23
Not yet open
Comparing the Therapeutic Efficacy of Extended Isthmusectomy Versus Total Thyroidectomy for Isthmus Tumors of the Thyroid
NCT07274605Thymectomy, Thyroid Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
520
Hangzhou
2025-12-19
Active, closed
Ultrasound Large-scale Model in Thyroid Field: A Multi-center Study on Medical-Engineering Integration
NCT07296575Thyroid Abnormalities, Thyroid, Thyroid Cancer
Second Affiliated Hospital of Nanchang University
Observational
2,000
Nanchang
2025-10-01
Not yet open
Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer
NCT06804863Thyroid Cancer, Regret
West China Hospital
Not applicable
600
Chengdu
2025-05-01
Recruiting
MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC
NCT07235566Thyroid Cancer
Fudan University
Phase 2
60
Shanghai
2025-04-21
Recruiting
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
NCT06860971Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
144
Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Gui'lin, Liuzhou
2025-04-18
Recruiting
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
NCT06937112Lung Cancers, Pancreatic Cancer, Neuroendocrine Tumors, Thyroid Cancer
Nanjing First Hospital, Nanjing Medical University
Observational
20
Nanjing
2025-04-10
Recruiting
The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
NCT06800768Thyroid Cancer
Ruijin Hospital
Observational
40
Shanghai
2025-02-01
Recruiting
Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)
NCT06730321Thyroid Cancer, Thyroid Nodule, Thyroid Diseases, Thyroid Cancer, Papillary
Shanghai 6th People's Hospital
Observational
200
Shanghai
2024-12-12
Not yet open
Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer
NCT06713057Locally Advanced Thyroid Gland Carcinoma, Thyroid Cancer
West China Hospital
Phase 2
20
Chengdu
2024-12-01
Recruiting
The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases
NCT06730529Thyroid Cancer
Ruijin Hospital
Observational
40
Shanghai
2024-11-29
Recruiting
Selective Neck Dissection Versus Modified Neck Dissection in PTC
NCT06554652Thyroid Cancer
Fudan University
Phase 3
250
Shanghai
2024-11-19
Recruiting
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
NCT07433283Tumor, Solid, Lung Cancer, Pancreas Cancer, Thyroid Cancer
Sichuan Enray Pharmaceutical Sciences Company
Phase 1/2
54
Beijing, Hunan, Chongqing, Fuzhou, Haikou, Heilongjiang, Shanghai, Chengdu
2024-11-12
Recruiting
Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer
NCT06787911Thyroid Cancer
Yu Wang
Phase 2
14
Shanghai
2024-07-24
Recruiting
RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer
NCT06530316Thyroid Cancer
Fudan University
Observational
48
Shanghai
2024-07-18
Recruiting
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
NCT06558981Thyroid Cancer
Fudan University
Phase 3
124
Shanghai
2024-07-11
Recruiting
RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer
NCT06524167Thyroid Cancer
Fudan University
Observational
80
Shanghai
2024-07-02
Recruiting
Renovated Prediction Model for Difficult Transoral and Submental Endoscopic Thyroidectomy
NCT06738888Thyroid Cancer, Thyroid Diseases, Thyroid Nodule
Shanghai 6th People's Hospital
Observational
300
Shanghai
2024-05-01
Recruiting
Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery
NCT06254859Thyroid Cancer, Thyroid Cancer, Papillary
Fujian Medical University
Observational
100
Fuzhou
2024-03-01
Active, closed
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
NCT05538130Melanoma, Glioma, Thyroid Cancer, Non-Small Cell Lung Cancer
Pfizer
Phase 1
148
Hangzhou, Wenzhou
2022-11-30
Active, closed
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID)
NCT05541380Thyroid Cancer
National Health Research Institutes, Taiwan
Observational
300
2022-08-29
Recruiting
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
NCT06087068Thyroid Cancer, Surgery, Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
140
Beijing
2022-08-01
Recruiting
A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer
NCT06082180Thyroid Cancer, Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
1,199
Beijing
2022-07-01
Recruiting
Iodine Nutrition Status and Clinical Characteristics of Thyroid Cancer
NCT06623500Thyroid Cancer
Shandong Provincial Hospital
Observational
1,600
Jinan
2012-01-01
Rows per page Showing 1–30 of 30
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/condition/thyroid-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 30 of those studies listing the condition Thyroid Cancer.

How many Thyroid Cancer trials are recruiting in China?

24 of the 30 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Thyroid Cancer), 30 studies
PhaseStudiesRecruitingShare
Observational121040%
Not applicable5316.7%
Phase 25416.7%
Phase 34413.3%
Phase 1216.7%
Phase 1/2113.3%
Phase EARLY_PHASE1113.3%

Most active sponsors

Lead sponsors with the most studies (Thyroid Cancer)
Lead sponsorStudiesRecruiting
Fudan University66
Shanghai 6th People's Hospital33
Cancer Institute and Hospital, Chinese Academy of Medical Sciences22
Fujian Medical University22
Ruijin Hospital22
West China Hospital20
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.11
FindCure Biosciences (ZhongShan) Co., Ltd.11
Nanjing First Hospital, Nanjing Medical University11
National Health Research Institutes, Taiwan10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.